Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Org Lett ; 2(20): 3095-7, 2000 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-11009354

RESUMO

The previously unreported alpha,alpha-disubstituted 1-aminoboronate esters have potential utility in peptidomimetic design, particularly against serine protease targets. A concise synthesis of 1-aminocyclopropaneboronate pinanediol ester is reported, and a peptidyl derivative is shown to have modest affinity (K(i) = 1.6 microM) for hepatitis C NS3 protease.


Assuntos
Ácidos Borônicos/síntese química , Ciclopropanos/síntese química , Hepatite C/enzimologia , Oligopeptídeos/química , Inibidores de Proteases/síntese química , Proteínas não Estruturais Virais/antagonistas & inibidores , Ácidos Borônicos/química , Ciclopropanos/química
2.
Chem Biol ; 5(7): 397-406, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9662506

RESUMO

BACKGROUND: Aminoglycoside antibiotics bind to the A-site of the decoding region of 16S RNA in the bacterial ribosome, an interaction that is probably responsible for their activity. A detailed study of the specificity of aminoglycoside binding to A-site RNA would improve our understanding of their mechanism of antibiotic activity. RESULTS: We have studied the binding specificity of several aminoglycosides with model RNA sequences derived from the 16S ribosomal A-site using surface plasmon resonance. The 4,5-linked (neomycin) class of aminoglycosides showed specificity for wild-type A-site sequences, but the 4,6-linked class (kanamycins and gentamicins), generally showed poor specificity for the same sequences. Methylation of a cytidine in the target RNA, as found in the Escherichia coli ribosome, had negligible effects on aminoglycoside binding. CONCLUSIONS: Although both 4,5- and 4, 6-linked aminoglycosides target the same ribosomal site, they appear to bind and effect antibiotic activity in different manners. The aminoglycosides might recognize different RNA conformations or the interaction might involve different RNA tertiary structures that are not equally sampled in our ribosome-free model. These results imply that models of ribosomal RNA must be carefully designed if the data are expected to accurately reflect biological activity.


Assuntos
Antibacterianos/farmacologia , RNA Bacteriano/efeitos dos fármacos , RNA Ribossômico 16S/efeitos dos fármacos , Antibacterianos/metabolismo , Concentração de Íons de Hidrogênio , Canamicina/metabolismo , Canamicina/farmacologia , Metilação , Neomicina/metabolismo , Neomicina/farmacologia , Concentração Osmolar , Paromomicina/metabolismo , Paromomicina/farmacologia , RNA Bacteriano/metabolismo , RNA Ribossômico 16S/genética , RNA Ribossômico 16S/metabolismo
3.
J Am Chem Soc ; 119(16): 3641-8, 1997 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-11540136

RESUMO

The specificity of neomycin B and related aminoglycoside antibiotics in their interaction with the Rev responsive element (RRE) of HIV-1 mRNA has been studied by directly observing the aminoglycoside-RNA complexes using surface plasmon resonance. Several different RNA sequences, each with a biotin tag, have been prepared using T7 RNA polymerase-catalyzed transcription of synthetic DNA templates and have been immobilized on a streptavidin-coated surface for the binding study. The results indicate that neomycin B is not specific for the G-rich bubble region in RRE. Rather, it appears to interact with three different sites, each with a submicromolar dissociation constant, within the 67-nucleotide domain II of RRE. Further analysis of neomycin B binding with three short synthetic RNA hairpins showed binding with submicromolar affinity and 1:1 stoichiometry in each case. This suggests that neomycin B may generally bind with this affinity to regular A-form RNA or hairpin loops. The approach described here is generally useful for understanding the fundamental interactions involved in the specific recognition of nucleic acids by small molecules which is the basis of rational drug design.


Assuntos
Antibacterianos/metabolismo , Framicetina/metabolismo , Produtos do Gene rev/metabolismo , Genes env , HIV-1/genética , RNA Viral/metabolismo , Antibacterianos/química , Afinidade de Anticorpos , Sequência de Bases , Sítios de Ligação , Biotinilação , Química Farmacêutica , Framicetina/química , Produtos do Gene rev/química , Produtos do Gene rev/genética , HIV-1/química , Paromomicina/química , Paromomicina/metabolismo , Ligação Proteica , RNA Mensageiro/química , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , RNA Viral/química , RNA Viral/genética , Relação Estrutura-Atividade , Produtos do Gene rev do Vírus da Imunodeficiência Humana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...